Ajinomoto Bio-Pharma Services is a fully integrated Contract Development and Manufacturing Organization (CDMO) with a global presence encompassing facilities in Belgium, India, Japan, and the United States. We boast extensive experience (over four decades with high potency APIs and over seven decades with botanical extractions) and offer a comprehensive suite of services for pharmaceutical and biopharmaceutical development.

Ajinomoto Bio-Pharma Services specializes in scaling processes efficiently, from grams to commercial tonnages, through cGMP manufacturing and aseptic fill-finish capabilities for active pharmaceutical ingredients (APIs) and intermediates. We also leverage a broad spectrum of innovative platforms to expedite the transition from clinical/pilot stages to commercial production. These platforms encompass high potency API (HPAPI) handling, continuous flow manufacturing, biocatalysis, oligonucleotide synthesis, and antibody-drug conjugate (ADC) technologies.

Ajinomoto Bio-Pharma Services prioritizes exceptional quality and client satisfaction. Our commitment is reflected in a proven track record and a diverse, established customer base. Learn how Ajinomoto Bio-Pharma Services is set up to deliver high-quality, sustainably manufactured products on time.